Michael McCully

Company: Gate Neurosciences, Inc.

Job title: Co-Founder, President & Chief Executive Officer

Seminars:

Emerging Dosing Concepts for Plasticity-Enhancing Drugs: Insights Supporting a Phase 2 Study of Once-Weekly Oral Zelquistinel in MDD 1:30 pm

Event-driven pharmacology is a new and important concept in emerging psychiatry treatments Understanding metaplasticity and optimizing repeat dose strategies Leveraging symptom clusters and objective biomarkers to stratify patientsRead more

day: Track 2: Translational & Clinical